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Abstract
In the United States, the blacklegged tick, Ixodes scapularis, is a vector of seven human pathogens, 
including those causing Lyme disease, anaplasmosis, babesiosis, Borrelia miyamotoi disease, 
Powassan virus disease, and ehrlichiosis associated with Ehrlichia muris eauclarensis. In addition 
to an accelerated rate of discovery of I. scapularis-borne pathogens over the past two decades, the 
geographic range of the tick, and incidence and range of I. scapularis-borne disease cases, have 
increased. Despite knowledge of when and where humans are most at risk of exposure to infected 
ticks, control of I. scapularis-borne diseases remains a challenge. Human vaccines are not 
available, and we lack solid evidence for other prevention and control methods to reduce human 
disease. The way forward is discussed.
Ixodes scapularis-Borne Disease Agents Are an Increasing Public Health 
Concern
Among the approximately 50 000 locally acquired vector-borne disease cases reported 
annually from the contiguous United States, roughly 95% are caused by tick-borne 
pathogens and >70% are Lyme disease [1]. Lyme disease is caused by the spirochetes 
Borrelia burgdorferi sensu stricto (herein referred to as B. burgdorferi) [2], or much less 
commonly by Borrelia mayonii [3]; both are transmitted by the blacklegged tick, Ixodes 
scapularis (including the junior synonym, Ixodes dammini) in the eastern United States 
where the vast majority of cases occur [4,5]. Over the past two decades, we have seen 
expansions in both the geographic range of I. scapularis [6] (Figure 1A,B) and the incidence 
and geographic range of Lyme disease and other I. scapularis-borne diseases [7,8] (Figure 
1C,D). In addition, new I. scapularis-borne human pathogens continue to be discovered. As 
of 2017, seven microorganisms transmitted by I. scapularis – including five bacteria 
(Anaplasma phagocytophilum, Bo. burgdorferi, Bo. mayonii, Bo. miyamotoi, and E. muris 
eauclarensis), one protozoan parasite (Babesia microti), and one virus (Powassan virus) – are 
known to cause illness in humans [7,9]. The recognition of this diverse guild of I. scapularis-
borne pathogens over the last five decades marks a significant shift in the perceived medical 
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importance of the tick; prior to 1970, I. scapularis was not considered an important vector of 
human pathogens (Figure 2).
Humans are incidental hosts (see Glossary) of I. scapularis and its associated pathogens; 
although humans may be bitten [10,11], they are not essential for either the survival of tick 
populations or pathogen perpetuation (Figure 3). I. scapularis is a woodland-associated, 
three-host tick with a life cycle of 2–4 years [12,13]. Immature ticks (larvae and nymphs) 
have a broad host range, including rodents, insectivores, birds, lagomorphs, and ungulates 
[14,15]; whereas adults are restricted to medium- and large-sized mammals, primarily white-
tailed deer (Odocoileus virginianus) [16]. With the exception of Powassan virus and Bo. 
miyamotoi relapsing fever spirochetes, which can be passed transovarially as well as 
acquired through blood-feeding [17,18], the other five human pathogens transmitted by I. 
scapularis are not known to be maintained transovarially, and acquisition by ticks therefore 
occurs during blood feeding [4,17,19–23].
Many different personal protective measures to prevent tick bites, and control strategies to 
reduce tick abundance or disrupt pathogen transmission cycles, have been evaluated and 
demonstrated to be effective at preventing tick bites or reducing the abundance of host-
seeking ticks or infection rates in ticks or reservoir hosts [24–26]. These approaches include: 
tick repellents and permethrin-treated clothing to prevent human–tick contact; synthetic 
chemicals, natural products, and biological agents to suppress host-seeking ticks; deer 
reduction to suppress tick populations; topical application of pesticides to reduce tick 
burdens on rodents and deer; and antibiotic treatment or vaccination of rodent reservoirs 
against Lyme borreliosis spirochetes [27]. However, very few approaches have been 
evaluated with tick-borne diseases as an outcome measure, and we lack evidence for any 
currently available personal protective measure or environmentally-based tick/pathogen-
control method to consistently reduce I. scapularis-borne infections [28,29]. Herein, we 
describe the rise of I. scapularis and its associated diseases, and discuss control opportunities 
and challenges.
Ixodes scapularis Is Reclaiming Its Historical Range
Tick surveillance is not standardized or routine, thus hampering our ability to monitor 
changes in the distribution and abundance of I. scapularis [6,30]. Retrospective review of I. 
scapularis records reveals remarkable range expansion over the past century, particularly in 
the northern portion of the eastern United States. The earliest record of the tick in the 
northeast dates back to the 1920s near Cape Cod, Massachusetts [31]. By 1945, I. scapularis 
was recorded sporadically from states along the northern Atlantic coast, but its core 
distribution was primarily in the Gulf Coast states and the southeast [10]. In the early 1960s, 
focal populations were reported along the New England coast and in Rhode Island, and later 
in that decade records emerged from Long Island, New York, and northwestern Wisconsin. 
During the 1970s, the reported distribution of the tick expanded, and its abundance increased 
along the Atlantic coast from New England to the mid-Atlantic states; expansion inland 
continued through the 1980s and 1990s [30,31].
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Moreover, compilations of I. scapularis county collection records revealed that over the past 
two decades the tick’s range has expanded substantially in the upper Midwest, northeast and 
mid-Atlantic states, but remained stable in the southeast (Figure 1A,B). As of 2016, I. 
scapularis had been documented in nearly half (1420 of 3110 counties) of the counties in the 
contiguous United States; in total, 842 counties across 35 eastern and central states are 
believed to have established populations [6]. Overall, during the past two decades, the 
number of counties in which I. scapularis is considered to be established has more than 
doubled. Recent habitat suitability models for I. scapularis identified many eastern counties 
as environmentally suitable for the tick to become established but from which it has not yet 
been reported, implying that the tick is still under-reported [32,33].
These geographical trends appear to represent a species reclaiming its historical range. 
Phylogeographic studies suggest that the tick’s historical range likely extended across much 
of the eastern United States. It is likely that the species originated in the southern United 
States a half a million years ago, with later expansion into the mid-Atlantic and northeastern 
United States roughly 50 000 years ago, followed by colonization of the upper Midwest in 
the last 20 000 years following the retreat of the Laurentide Ice Sheet [34].
Environmental changes over the past 200 years drastically altered the distribution of I. 
scapularis, particularly in the northeast. Rapid deforestation to accommodate agriculture and 
to provide fuel, coupled with near elimination of white-tailed deer through hunting and 
habitat loss during the 1800s and early 1900s, likely restricted the range of this woodland 
tick that strongly depends on deer for blood meals in the adult stage. Refugia sites were 
restricted to focal areas in the northeast and upper Midwest where forests remained intact 
[31,35]. By the second half of the 20th century, large portions of the northeast were 
converted from agricultural to suburban land, leading to reforestation with a spatial mosaic 
of woods of various ages and patch sizes intermingled with ornamental plants and 
maintained lawns [36]. During roughly the same time period, the increase in suitable habitat 
for deer resulted in dramatically increasing abundance of white-tailed deer [35].
Although compilation of presence records provides a reasonably accurate representation of 
the tick’s geographic range, lack of systematic vector surveillance limits accuracy in the 
estimation of geographic variation in the density of host-seeking I. scapularis nymphs, a 
variable that is more closely associated with Lyme disease incidence than measures of tick 
presence [37–40]. Roughly a decade ago, a systematic collection effort was undertaken to 
assess variation in the density of host-seeking nymphal I. scapularis ticks throughout the 
eastern United States [41]. The study revealed that, although I. scapularis was widely 
distributed, the density of host-seeking nymphs was generally higher in the north compared 
with the south, mirroring the reported distribution of Lyme disease cases in the eastern 
United States (Figure 1C,D). The findings were consistent with previous reports that, 
although the tick is present in southern states, host-seeking I. scapularis nymphs are rarely 
collected by drag sampling [42–44] and seldom bite people [11,45]. Later studies revealed 
distinct differences in host-seeking behavior between northern and southern clades of I. 
scapularis. Specifically, southern ticks are less likely than their northern counterparts to 
ascend vegetation when seeking hosts [46,47], thus reducing the likelihood of tick–human 
encounters when compared with their northern counterparts. Since the last systematic effort 
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to document geographic variation in the density of host-seeking I. scapularis throughout its 
range in the United States [41], the tick’s range has expanded [6], and northern clade ticks 
appear to be spreading south [34]. Not surprisingly, the geographic range of counties 
classified as having high Lyme disease incidence has expanded following similar patterns 
[48]. A renewed effort to assess spatial variation in the density of host-seeking I. scapularis 
appears justified.
The Number of Recognized Human Disease Agents Transmitted by I. 
scapularis Is Growing
From 1970 through 2017, seven I. scapularis-borne human pathogens were described 
(Figure 2). In 1970, Ba. microti, an intraerythrocytic parasite, was first described in an 
otherwise healthy woman [49], (Figure 2). Shortly thereafter, Ba. microti was identified in 
white-footed mice (Peromysus leucopus) and in I. scapularis; experimental studies later 
confirmed that I. scapularis nymphs are capable of transmitting Ba. microti [50,51].
Lyme disease was first recognized in the United States as a new form of inflammatory 
arthritis in 1975 [52]. In 1982, a spirochete, later named Bo. burgdorferi [53], was identified 
as the etiological agent and shown to be transmissible by I. scapularis [2,5]. Although 
numerous small mammals and birds have been implicated as reservoirs of Bo. burgdorferi, 
the white-footed mouse is among the most important reservoirs in the eastern United States 
[15,36,54,55].
Human granulocytic anaplasmosis, originally described as human granulocytic ehrlichiosis 
(Ehrlichia phagocytophila), was first identified in six patients from northern Minnesota and 
Wisconsin presenting with acute febrile illnesses between 1990 and 1993. The timing of 
onset of cases was consistent with host-seeking activity of I. scapularis and Dermacentor 
variabilis and the former was implicated as a vector based on evidence that the closely 
related Ixodes ricinus transmits E. phagocytophila in Europe [56]. In 1996, I. scapularis was 
experimentally confirmed as a vector of E. phagocytophila, and P. leucopus was shown to be 
a competent reservoir [57]. In 2001, this intraleukocytic bacterium was renamed A. 
phagocytophilum [58].
Powassan virus, a flavivirus, was first recognized as a human pathogen in 1958 when it was 
isolated from a child who died of encephalitis [59]. Ixodes marxi, Ixodescookei, and Ixodes 
spinipalpis were implicated as enzootic vectors of Powassan virus in the 1960s [60–62], 
more than 30 years before experimental vector competence was demonstrated for I. 
scapularis [17]. Owing to its greater propensity to bite humans, I. scapularis is considered 
the primary bridging vector of Powassan virus (also referred to as ‘Deer Tick virus’ or 
‘lineage II Powassan virus’) to humans [17,19,63].
In 2011, a novel obligate intracellular Gram-negative bacterium, found in I. scapularis from 
Minnesota and Wisconsin and later described as E. muris eauclarensis [64], was recognized 
to cause ehrlichiosis in humans [65]. I. scapularis was demonstrated experimentally to be a 
vector of E. muris eauclarensis [20,66], supporting earlier reports of natural infection in I. 
scapularis from Minnesota and Wisconsin [65,67,68]. E. muris eauclarensis has been 
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detected in naturally infected white-footed mice collected in these two states [69], and 
reservoir competence was demonstrated in the laboratory [66].
Bo. miyamotoi, a relapsing fever spirochete, was first described in Ixodes persulcatus in 
Japan [70]. In 2001, the ability of I. scapularis to transmit Bo. miyamotoi while feeding, and 
to pass spirochetes transovarially, was demonstrated under laboratory conditions [71]. A 
decade later, Bo. miyamotoi was recognized as a human pathogen in a report of 46 cases 
from Russia [72]. Shortly thereafter, the first recognized case of Bo. miyamotoi disease in 
North America was described in an 80-year-old woman from New Jersey [73]. The first 
large case series from the northeastern United States revealed that the peak onset of illness 
occurs from July through August – 1 month later than for Lyme disease, anaplasmosis, and 
babesiosis – and thus corresponds with the peak host-seeking activity of larval rather than 
nymphal I. scapularis ticks [74,75]. Although white-footed mice support short-lived 
infections of Bo. miyamotoi transmissible to feeding ticks and likely play a role in 
amplification of infections [71,76], transovarial transmission may be the primary route of 
enzootic maintenance [76–79].
Until 2016, when Bo. mayonii was described and recognized as a causative agent of Lyme 
disease in Minnesota and Wisconsin [3,80], Bo. burgdorferi had been considered the sole 
agent of Lyme disease in the United States. Bo. mayonii has been detected in field-collected 
I. scapularis from Minnesota and Wisconsin [3], and vector competence has been 
demonstrated under laboratory conditions [4]. Bo. mayonii also was isolated from white-
footed mice and an American red squirrel (Tamiasciurus hudsonicus) in Minnesota, but 
reservoir competence has not yet been demonstrated experimentally [81].
Coinfections Are Common in I. scapularis and May Increase Severity of 
Illness in Humans
Coinfections are commonly reported in I. scapularis, most often dual infections of Bo. 
burgdorferi with either A. phagocytophilum or Ba. microti [82–91]. Because of small sample 
sizes and lack of systematic efforts to assess trends over the geographic range of I. 
scapularis, the true prevalence of coinfections remains unknown. Based on limited data, 
prevalence of dual infections varies over time and by geographic region and has been 
reported in 1–28% of ticks tested, but commonly less than 5–10% of ticks are coinfected 
[89–91].
Bo. burgdorferi and Ba. microti share a common reservoir, the white-footed mouse, 
explaining the increased likelihood of finding coinfections more often than expected by 
chance [85,86,91]. Recent evidence suggests that Bo. burgdorferi promotes transmission of 
Ba. microti, and the former typically becomes established in new foci before the latter 
[85,86,91,92]. By contrast, coinfection with Bo. burgdorferi and A. phagocytophilum are 
typically observed at rates expected based on prevalence of each infection individually, 
suggesting independent enzootic transmission maintenance cycles [83,84,87,93]. Although, 
the efficiency of I. scapularis to transmit Bo. burgdorferi or A. phagocytophilum is not 
affected by coinfection [84], coinfection in mice has been shown to increase pathogen 
acquisition by feeding larvae, compared with rates observed when feeding on singly infected 
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mice [94]. The relative abundance of various hosts in a community likely influences the 
probability of coinfections occurring. Although reported less commonly as a coinfection 
with Bo. burgdorferi compared with A. phagocytophilum or Ba. microti, coinfection with 
Bo. miyamotoi appears to occur at rates expected by chance, or lower, again suggesting 
independent mechanisms of persistence [76,82].
Coinfections with I. scapularis-borne pathogens in humans can arise from the bite of a single 
coinfected tick, or from concurrent bites by multiple singly-infected ticks. Although 
differences in methods of detecting infections differ across studies of persons diagnosed 
with tickborne diseases, and across studies from the northeastern and upper Midwestern 
United States, coinfection rates ranged from 0 to 67% for Lyme disease and babesiosis, 0 to 
26% for Lyme disease and anaplasmosis, and 0 to 7% for anaplasmosis and babesiosis [90]. 
As reviewed previously, concurrent infections with Bo. burgdorferi and Ba. microti or A. 
phagocytophilum appear to increase severity of illness [90,91].
Incidence and Ranges of Diseases Caused by I. scapularis-Borne 
Pathogens Are Increasing
I. scapularis-borne pathogens are associated with four nationally notifiable diseases. Lyme 
disease was added to the list of notifiable conditions in 1991; anaplasmosis, Powassan virus 
disease, and babesiosis were included in 2000, 2002, and 2011, respectively. Case counts 
have generally increased for each of these conditions since they became notifiable (Figure 
4). From 2002 to 2016, a total of 102 Powassan virus disease cases have been reported, with 
annual case counts ranging from 0 to 22 casesi. By contrast, since 2008, annual reported 
cases of Lyme disease have exceeded 30 000, marking a near tripling of reported cases since 
it was first notifiable in 1991 [8,95]. Notably, the number of cases reported is estimated to be 
approximately tenfold lower than the number of Lyme disease cases that are diagnosed 
annually [96,97]. Reported cases of anaplasmosis increased from 351 in 2000 to 4151 in 
2016, and reported cases of babesiosis have increased from 1128 in 2011 to 1910 in i.
Compared with Lyme disease, the incidence of reported anaplasmosis, Powassan virus 
disease, and babesiosis is several orders of magnitude lower, and their geographic 
distribution appears to be similar but more restricted; like the distribution of Lyme disease 
cases, the geographic range of anaplasmosis and babesiosis has similarly spread over time 
(Figure 4) [7,19,95,98,99]. Over 96% of Lyme disease cases are reported from just 14 states 
in the northeast, mid-Atlantic and the upper Midwest [95]. Since the mid-1990s, the number 
of counties with a high incidence of Lyme disease has increased by approximately 300% 
[48]. As it is not a notifiable condition, trends in incidence and geographic range of Bo. 
miyamotoi disease cases are not well characterized, but the geographic range is likely 
similar to that of Lyme disease [100]. By contrast, ehrlichiosis, caused by E. muris 
eauclarensis, thus far has been reported only from the upper Midwest [65].
iResources
wwwn.cdc.gov/nndss/default.aspx
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Controlling I. scapularis and Reducing Tick-Borne Diseases Is Challenging
The Evidence Base for Existing Interventions to Reduce Human Tick-Borne Disease Is 
Weak
Perhaps the most vexing aspect of control of I. scapularis-borne diseases, as exemplified by 
Lyme disease, is that we already know (i) the geographic areas in which the majority of 
cases will occur each year, and (ii) the months of the year during which most of the 
infections will be acquired [95]. In the Lyme disease focus in the northeast, we also know 
that humans most often encounter I. scapularis ticks in peridomestic settings, including on 
their own residential properties [26,37]. Despite this detailed knowledge of when and where 
humans are most at risk for exposure to infected ticks, we remain unable to control I. 
scapularis-borne diseases.
Previous reviews have addressed (i) personal protective measures to reduce human contact 
with I. scapularis ticks and environmentally based control methods to suppress host-seeking 
ticks and reduce infection with Lyme disease spirochetes in tick vectors and rodent 
reservoirs [25–27,101]; (ii) the evidence base for such measures, and methods to reduce 
Lyme disease [28,29,102,103]; and (iii) the prospect for a human Lyme disease vaccine to 
re-emerge in the wake of the rise and fall of Lymerix, an effective licensed vaccine that was 
removed from the US market in 2003 [104,105]. Despite the emergence of a wide array of 
approaches to avoid contact with ticks through personal protective measures, suppress host-
seeking I. scapularis, or disrupt enzootic B. burgdorferi transmission, we unfortunately still 
lack robust evidence for any method other than a human Lyme disease vaccine to reduce 
disease cases. When thinking about strengths and weaknesses of methods to prevent I. 
scapularis-borne infections, we find it useful to illustrate the chain of events leading to a 
case of I. scapularis-borne infection (using Lyme disease as an example) and, working 
backwards from the human infection, define and discuss the points where we can potentially 
intervene (Figure 5).
Disease Resulting from Bites by Infected Ticks Can Be Prevented by Early Tick Detection 
and Removal, Antibiotic Prophylaxis, and, in the Future, Hopefully Also by Vaccines
The most proximate intervention to prevent a human infection caused by an I. scapularis-
borne pathogen is to ensure that the bite of an infected tick does not result in illness (Figure 
5). Although this intuitively is the most impactful intervention point, all currently available 
intervention methods suffer from the shortcoming of being reliant on detection of attached 
ticks. The fact that I. scapularis nymphs are notoriously difficult for people to detect while 
biting [106] limits the usefulness of both removal of an attached infected nymph before it 
can transmit a pathogen [107] and antibiotic prophylaxis following a recognized tick bite 
[108]. This could potentially be overcome with a new type of consumer product to kill 
attached ticks without first having to detect their presence, such as an acaricidal skin lotion 
or shower soap. However, even this solution has practical limitations because it will require 
daily use and would be effective only if the soap or lotion is applied directly onto an 
unrecognized biting tick. Moreover, the tick would be attached for some period of time 
before being impacted, thus increasing the risk for pathogen transmission.
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Potential future magic bullet solutions, capable of both ensuring that the bite of an infected 
tick does not result in illness and having the potential to rapidly and dramatically reduce I. 
scapularis-borne human infections at the population level, include (i) human vaccines or 
prophylactic antibody treatments against Lyme disease spirochetes or other I. scapularis-
borne pathogens [104,105,109,110], and (ii) transmission-blocking anti-tick vaccines for 
human use with potential for simultaneous protection against multiple I. scapularis-borne 
pathogens [111–115]. These approaches would not require daily action and vigilance, and 
they would be effective regardless of whether or not bites by infected ticks are noticed. If 
proven to be safe, effective, and acceptable for widespread use, there is no question that the 
re-emergence of a human vaccine against Bo. burgdorferi, or the emergence of a 
prophylactic antibody treatment, would be the most effective ways to rapidly reduce Lyme 
disease cases. However, neither approach would address the remaining I. scapularis-borne 
pathogens, several of which are on the rise (Figure 4). A transmission-blocking anti-tick 
vaccine could potentially address that shortcoming, but only if it proves to act quickly and 
effectively enough on an infected tick to prevent or substantially reduce the likelihood of 
pathogen transmission occurring before the tick is incapacitated. These urgently needed 
approaches merit greater resources to expeditiously move them forward in a pipeline from 
prevention concept to proven solution and become, should they be successful, cornerstones 
in public health programs to reduce I. scapularis-borne infections.
Use of Repellents and Permethrin-Treated Clothing Can Reduce the Risk of Tick Contact 
Resulting in Bites
The next point of intervention to prevent a human infection is to ensure that ticks making 
contact with human skin or clothing do not get an opportunity to bite (Figure 5). This can be 
achieved by the use of tick repellents on skin and clothing, or the use of permethrin-treated 
clothing [27,116], combined with regular checks for crawling ticks, changing clothes when 
coming inside (and drying removed clothing articles at high heat), and taking a shower 
(ensuring removal of clothes worn outside, increasing the likelihood of detecting crawling 
ticks, and perhaps also dislodging crawling ticks while showering) [25,29,95]. The main 
problem is that all of these actions require a level of daily vigilance and effort that is hard to 
keep up for the period of 2–3 months during which I. scapularis nymphs are most active. 
Another problem is that we lack knowledge of how specific use patterns for repellents and 
permethrin-treated clothing, including frequency of use and extent of the body protected, 
may impact their protective effect against tick bites.
Risk of Contact with Host-Seeking Ticks Can Be Minimized by Behavioral Change, 
Environmental Modification, and Killing of Host-Seeking Ticks
Even further distant from the human infection, we can intervene by minimizing contact with 
host-seeking ticks (Figure 5) through (i) avoidance of habitats with a high risk for tick 
contact (easier said than done if it includes your backyard), (ii) reduction in longevity or 
survival of desiccation-sensitive host-seeking I. scapularis ticks in the peridomestic 
environment (e.g., xeriscaping, hardscaping, and vegetation management, including keeping 
grass short, clearing brush and removing leaf litter), or (iii) direct killing of host-seeking 
ticks with acaricides or biological control agents [24,25,27,29,117]. Here we introduce 
increased complexity by relying on solutions that are highly sensitive to human movement 
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patterns. For example, controlled experimental spring applications of pyrethroids typically 
reduce host-seeking I. scapularis nymphs by >85% [27]. Nevertheless, a recent effort to 
reduce tick bites and human I. scapularis-borne infections by spraying pyrethroids along the 
lawn–wood interface on residential properties, rather than treating all the wooded and brushy 
high-risk habitat on the properties, achieved 50–70% suppression of host-seeking I. 
scapularis nymphs within the areas sprayed but failed to reduce either tick bites or human 
infection [118]. Suppression of host-seeking I. scapularis nymphs across all wooded or 
brushy habitats on a property, thereby getting closer to a desired goal of complete absence of 
ticks in this high-risk environment, intuitively should be more impactful but it is also more 
expensive and may come at higher environmental costs. It remains to be evaluated to what 
extent such an intervention can reduce tick-borne disease.
Production of Infected Ticks Can Be Suppressed by Targeting Important Tick Hosts and 
Pathogen Reservoirs
Finally, we can intervene by suppressing production of infected I. scapularis nymphs by 
disrupting enzootic pathogen transmission among tick immatures and vertebrate hosts acting 
as pathogen reservoirs (particularly rodents) and targeting key hosts for the adult stage 
(particularly white-tailed deer) to reduce overall tick populations (Figure 5). There is little 
doubt that the white-tailed deer is the engine that drove the remarkable surge in populations 
of I. scapularis seen across the northeast and upper Midwest over the last 50 years [31,35]. 
Intuitively, adult I. scapularis ticks feeding on white-tailed deer is the weakest point in the 
chain leading to tick population build-up and, ultimately, intensified enzootic transmission 
among tick immatures and pathogen reservoirs, and production of pathogen-infected I. 
scapularis nymphs. It therefore has been reasonably argued that addressing deer, either by 
population reduction to very low levels or topical/oral application of acaricides to a large 
proportion of the deer, should be viewed as a cornerstone of area-wide environmentally 
based integrated management programs for I. scapularis [25,26,101,103]. Although 
numerous methods targeting rodent reservoirs and white-tailed deer have emerged in the last 
30 years [27], questions remain about the extent of available animals within a given area that 
need to be removed or treated to achieve reduction of human tick bites and human disease 
[26,28,102,103]. These methods also can be sensitive to local vertebrate community 
structure (if alternative pathogen reservoirs are readily available for tick immatures or 
alternative hosts for adult ticks are abundant) or, when relying on food baits in the 
implementation, to natural variation in food sources for rodents or deer over time.
Integrated Intervention Approaches Need to Be Evaluated with Human Disease Outcome 
Measures
Barring the emergence of a magic bullet solution (human vaccine, prophylactic antibody 
treatment, or transmission-blocking anti-tick vaccine), no single personal protective measure 
or environmentally based tick/pathogen control method is likely to substantially reduce I. 
scapularis-borne infections when used in isolation [28]. A few integrated intervention 
approaches that combine two or three environmentally based control methods have been 
shown to effectively reduce abundance of host-seeking I. scapularis nymphs [26,27,119–
121], but none of these integrated approaches have yet been evaluated with the gold standard 
of human infection with an I. scapularis-borne pathogen as an outcome measure [28]. As 
Eisen and Eisen Page 9
Trends Parasitol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
suggested by the chain of events outlined in Figure 5, we also need to think outside the box 
and consider integrated intervention approaches that – rather than just combining two or 
more environmentally-based control methods – also include changes in human behavior and 
the use of existing personal protective measures.
We Need to Better Understand the Issues Relating to Cost, Acceptability, and Feasibility of 
Different Intervention Approaches
Another major challenge arises because control of I. scapularis and prevention of infection 
with its associated pathogens remains the responsibility of individual homeowners. Families 
therefore must make decisions regarding personal protective measures and environmentally 
based tick control on their properties, taking into consideration how much money they are 
willing to spend, under which circumstances (when and where) they wish to be protected, 
the level of daily effort required to achieve protection, and whether a given measure or 
method is acceptable to use. As illustrated in Figure 6, an ideal tick-borne disease prevention 
method should, from the perspective of a family, incur low cost, require minimal effort, and 
be globally effective (i.e., protective everywhere, all the time, and regardless of type of 
activity). It also must be acceptable for use. The scope of this challenge is illustrated by the 
most recently published survey of willingness to pay for tick control [122], which found that 
most residents in a Lyme disease endemic setting in Connecticut were unwilling to spend 
more than $100 per year and that acceptability was limited for some methods, including the 
use of acaricides to kill host-seeking ticks.
The magic bullet approaches discussed above (human vaccine, prophylactic antibody 
treatment, or transmission-blocking anti-tick vaccine) come closest to solving the 
‘impossible tribar’ of low cost, minimal effort, and global effectiveness, should they emerge 
and prove to be safe, effective, and widely acceptable for use (Figure 6). All currently 
available personal protective measures or environmentally based control methods fall short 
for at least one of the three desired characteristics, and some likely also will have limited 
acceptability. This, in turn, raises the intriguing question of which characteristic a majority 
of families is willing to give up: low cost, minimal effort, or global effectiveness? We 
therefore need to consider not only whether solutions to reduce I. scapularis-borne infections 
can be applied by individual families/on individual properties or may require 
implementation at a neighborhood/community scale, but also which solutions can achieve 
specific combinations of at least two desired characteristics: low cost–minimal effort, low 
cost–global effectiveness, or minimal effort–global effectiveness. Finally, we note that the 
process of moving promising solutions to reduce I. scapularis-borne infections forward in a 
pipeline from prevention concept to proven solution and successful public health program 
currently is impeded by an order of magnitude shortcoming in the financial resources 
available to achieve this effectively and expeditiously.
Concluding Remarks
In recent decades, I. scapularis has become more widespread, and an increasing number of 
microorganisms transmitted by this tick have proven to be pathogenic in humans. In parallel, 
both the incidence and geographic range of reported cases of I. scapularis-borne diseases 
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have increased, and coinfections are increasingly being recognized to contribute to severity 
of illness. Moreover, habitat suitability models suggest that the tick’s potential range exceeds 
the current reported distribution, suggesting either under-reporting of the tick’s current range 
or the potential for range expansion (see Outstanding Questions). Because the presence of 
the vector tick is a prerequisite for human tick-borne infections, we recognize a need to 
monitor changes in the distribution of I. scapularis. Recognizing that the density of host-
seeking infected nymphs provides a better estimate of human risk for bites by infected ticks 
than measures of tick presence, we emphasize the need to assess spatial variation in the 
density of infected host-seeking nymphs in order to educate the public of changing risk 
patterns. Such studies should (i) use standardized sampling methodology, (ii) be conducted 
during the expected peak in nymphal host-seeking, (iii) use sensitive and specific pathogen-
detection assays that are capable of detecting coinfections, (iv) report the density of 
pathogen-infected host-seeking nymphs (the life stage most often associated with human 
infections) per sampling site, and (v) use appropriate statistical methods to extrapolate 
predictions about the measured outcomes to areas that were not sampled. Moreover, there is 
a critical need for intervention approaches with proven capacity to reverse the growing 
public health problem imposed by I. scapularis (see Outstanding Questions). We need 
intensified and sustained efforts to develop safe and effective human vaccines, prophylactic 
antibody treatments, and transmission-blocking anti-tick vaccines, as well as a stronger 
evidence base for the capability of other already available personal protective measures and 
environmental control methods to reduce tick-borne disease, especially for integrated 
intervention approaches. Although proof-of-concept studies will logically focus on 
acarological or zoonotic outcomes (e.g., tick or host abundance, infection rates in ticks or 
hosts), ultimately evaluations of prevention strategies with human disease outcomes are 
needed.
Outstanding Questions
How widespread is I. scapularis?
How does the density of infected host-seeking nymphs change across the species’ 
range?
Are E. muris eauclarensis and Bo. mayonii restricted to the upper Midwest and, if 
so, why?
As previously distinct northern I. scapularis foci in the upper Midwest and 
northeast are merging, how will this affect the distribution of I. scapularis-borne 
pathogens?
Why is the prevalence of Bo. miyamotoi in ticks so low compared with Bo. 
burgdorferi, given that the former is transmitted transtadially and transovarially 
and the latter is transmitted only transtadially?
Among the potential control strategies, which has the greatest potential to reduce 
the incidence of I. scapularis-borne disease cases? Given that none of the current 
options can combine low cost, minimal effort, and global effectiveness, which 
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characteristic is a majority of families willing to give up: low cost, minimal effort, 
or global effectiveness?
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Glossary
Bridging tick vectors
ticks that acquire pathogens from zoonotic hosts involved in enzootic transmission cycles 
and later transmit pathogens to incidental hosts, which, in the case of tick-borne pathogens, 
include humans.
Coinfection
simultaneous infection with two or more pathogens within the same vector or host.
Drag sampling
a method of collecting host-seeking ticks in which a blanket is dragged across vegetation, 
typically over fixed distances or amounts of time, usually in an effort to quantify the 
abundance or density of host-seeking ticks. It is generally considered a better measure of the 
risk for human encounters with ticks than measures of tick abundance on hosts.
Enzootic tick vectors
ticks that transmit the pathogen of interest among zoonotic hosts.
Host-seeking
behavior displayed by a tick in an attempt to find a bloodmeal host (e.g., ascending 
vegetation and waiting for a host to pass by).
Incidental hosts
hosts that are not essential to the tick’s life cycle or perpetuation of tick-associated 
pathogens.
Magic bullet
something providing an effective solution to a difficult or previously unsolvable problem.
Relapsing fever spirochetes
phylogenetically related to Lyme disease spirochetes, but relapsing fever spirochetes are 
typically transmitted by soft (argasid) ticks (with the notable exception of a few hard-tick-
borne species, including Borrelia miyamotoi), and transovarial transmission is common. In 
contrast, Lyme disease spirochetes are transmitted by hard (ixodid) ticks and are not 
maintained transovarially.
Reservoirs
organisms in which a pathogen can survive and reproduce, for some period of time, and that 
contribute to enzootic maintenance.
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Transovarial transmission
passage of infection from an infected adult female tick to her eggs.
Vector ticks
ticks capable of acquiring infection during blood-feeding or transovarially, remaining 
infected through transition to subsequent life stages, and infecting a susceptible host while 
feeding.
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Highlights
The blacklegged tick, Ixodes scapularis, is becoming more widespread in the 
eastern United States.
The number of I. scapularis-borne microorganisms recognized to be pathogenic in 
humans is increasing.
The incidence of I. scapularis-borne disease cases continues to increase.
The geographic distribution of human cases of I. scapularis-borne diseases is 
expanding.
There is a critical need for control approaches with proven capacity to reverse the 
growing public health problem imposed by I. scapularis.
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Figure 1. 
Reported Distribution of Ixodes scapularis in 1996 (A) and 2016 (B); and Reported Cases of 
Lyme Disease in 2001 (C) and 2015 (D).
Counties classified as established, based on <6 individual ticks of a single life stage or >1 
life stage reported per county in a year are shown in red. Counties classified as reported 
based on <6 individual ticks reported in a year are shown in blue. Data from A and B are 
derived from Dennis et al. [30] and Eisen et al. [6], respectively. In panels C and D, one dot 
was placed randomly within the county of residence for each reported case. In the far-
western United States, Ixodes pacificus serves as a vector of Borrelia burgdorferi.
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Figure 2. 
Timeline Showing Discovery of the Seven Human Pathogens Transmitted by Ixodes 
scapularis.
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Figure 3. 
Life Cycle of Ixodes scapularis.
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Figure 4. 
Reported Cases of Babesiosis, Anaplasmosis, and Lyme Diseases in the United States, 
1996–2016. Source: https://wwwn.cdc.gov/nndss/data-and-statistics.html (last referenced 
November 13, 2017).
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Figure 5. 
Chain of Events Leading to a Lyme Disease Infection, with Possible Intervention Points for 
Different Control Approaches.
Eisen and Eisen Page 24
Trends Parasitol. Author manuscript; available in PMC 2018 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 6. 
Desired Characteristics of an Ideal Tick-Borne Disease Prevention Method.
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